China Vaccine Focus (CVF2011)
Venue: Crowne Plaza Sun Palace
|Event Date/Time: Jun 09, 2011||End Date/Time: Jun 10, 2011|
China Vaccine Focus 2011
â€“ Where Global and Chinese Domestic Vaccine Giants Converge to Discuss New Business Opportunities
Beijingâ€¦June 9th â€“ 10th, 2011â€¦will welcome the opening of China Vaccine Focus 2011 (CVF2011), expectedly a grand gathering of 300+ senior level executives from global vaccine fraternity in China and elsewhere around the world.
What do Chinaâ€™s "Twelfth Five-Year Plan" and new GMP regulation ring to domestic and foreign vaccine players? How to align vaccine development strategies with changing business landscape? Centered around the topic of "Developing Safe, Reliable, High Yield Vaccines for a Healthier World", CVF2011 will track various focus points on vaccines for infectious diseases, non-infectious diseases, AIDS vaccines, cancer vaccines, RNA/DNA vaccines, and point to the best opportunities for R&D partnering and manufacturing excellence.
By the present of senior officials from Ministry of Health, PRC, SFDA/ FDA, NICPBP to address the latest regulatory issues on development of China vaccine industry. Through two daysâ€™various sessions such as keynote presentations, interactive panel discussions, case studies, cocktail party and scheduled one-to-one business meetings, you will hear the perspectives of both Chinese and MNC vaccine leaders. They will provide insights into their own company strategies for the coming years and how each perceives the marketplace developments. It will help you to win the vaccine market competition and strengthen your companyâ€™s dynamic growth in Chinaâ€™s vaccine market.
CVF2011 is one of the major international functions that link global and Chinese vaccine executives from all over the world together. CVF2011 will provide the most integrated platform for partnerships at both a strategic & technical level, and it will influence the whole China, even global vaccine industry with positive and strong stimulation, herewith save the dates of June 9 -10 on your 2011 calendar & secure your seats today!
ïƒ¼ Official Guideline Panel:
Official Guideline Panel is where senior officials from SFDA, FDA, CCDC and NICPBP will blueprint the clearer views on the updated government policies and development prospects of China's vaccine industry. You will have the unique chance to raise your concerns and have your burning questions answered.
ïƒ¼ R&D Focused Stream:
R&D Stream is where vaccine experts from pharmas and biotechs will discuss the latest vaccine development in the industry. They will provide insights into their own companyâ€™s vaccine R&D strategies for the coming years and cover updates on adjuvants and delivery technologies for vaccines.
ïƒ¼ Manufacturing Focused Stream:
Manufacturing Stream will address the new GMP compliance issue, safety evaluation and quality control over vaccines, and how to leverage on technology and equipment advancements for optimized vaccine bioprocessing and production.
ïƒ¼ Pre-scheduled One-to-One Meetings:
CDMC online partnering system allows you to easily pre-arrange meetings online with potential partners before coming to the forum, to have private conversations and to make deals on site.
ïƒ¼ Vaccine Service Exhibition:
An international exhibition of global vaccine fraternity to showcase their products, services and technologies.
Featured speakers including:
Zhaohui WU, Secretary General, China Medicinal Biotech Association (CMBA)
Bing ZENG, Vice President, Sinopharm Group
Olivier CHARMEIL, Senior Vice President, Sanofi Pasteur
Xianze SUN, Director, Department of Drug Safety & Inspection, State Food and Drug Administration
Christopher HICKEY, Country Director, China, The US Food and Drug Administration
Xiaofeng LIANG, Director of the National Immunization Program, The Chinese Center for Disease Control and Prevention (CCDC)
Yunlong LI, Director, National Institute for the Control of Pharmaceutical and Biological Products (NICPBP)
Weidong YIN, President, Sinovac Biotech Ltd
Dr. Jean-Paul PRIEELS, Senior Vice President, R&D, GlaxoSmithKline Biologicals
Dr. Theodore TSAI, Senior Vice President, Scientific Affairs, Novartis Vaccines and Diagnostics, Inc
Zuolin HUANG, Vice President, Wuhan Biological Products Institute
Dr. Shou-Bai CHAO, Vice President, Manufacturing, MedImmune
Dr. Joe Zhou, CEO, Genor Biopharma
Any many othersâ€¦
Who should attend?
CVF2011 is a must-attend event for all top level executives and decision makers who are involved in vaccine R&D, manufacturing and long term growth strategy: We anticipate participants and presenters representing a broad array of institutions, with the largest number of delegates from multinational pharmaceutical & life sciences companies, biotechs and research institutions. Geographically, besides the delegates from Mainland China, a large number will be traveling from other Asian countries (Japan, Taiwan, India, Singapore, Australia, Korea, Malaysia, Thailand, Philippines), Europe, and the United States. This diversity will allow a strong exchange of opinions and ideas.
ï¬ VP/Directors of Manufacturing production / Regulatory Affairs
ï¬ Senior Scientists/Faculty Head
ï¬ VP/Directors of Vaccines/ R&D/ Scientific Affairs
ï¬ Business Development
Preferred partners for the conference program:
ï¬ Vaccine companies
ï¬ Vaccine delivery technology providers
ï¬ Vaccine adjuvant technology providers
ï¬ Venture capitalists
ï¬ Manufacturing equipment providers
ï¬ Bioprocess technology providers
ï¬ Cell culture and cell lines development technology providers
ï¬ Clinical research organizations
ï¬ Contract research organizations
ï¬ Contract manufacturing organizations
ï¬ Facility design consultants
ï¬ Law firms
ï¬ Vaccine distributors
ï¬ Distribution, logistics and warehousing solution providers
ï¬ Cold chain solution providers
ï¬ Packaging solutions providers
ï¬ Fill and finish solution providers
For more information, please visit: www.chinavaccinefocus.com